{"DataElement":{"publicId":"2974485","version":"1","preferredName":"Cowden Syndrome Diagnostic Criterion Name","preferredDefinition":"Text term representing a diagnostic criterion of Cowden Syndrome, a hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies, papules of the face and oral mucosa, and other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.","longName":"CWD_SYN_DX_CRIT_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2974439","version":"1","preferredName":"Cowden Syndrome Diagnosis","preferredDefinition":"A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"COWD_SYN_DX","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2974437","version":"1","preferredName":"Cowden Syndrome","preferredDefinition":"A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.","longName":"C3076","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cowden Syndrome","conceptCode":"C3076","definition":"An autosomal dominant hereditary syndrome characterized by a variety of hamartomas and neoplasms including verrucous skin lesions, fibromas of the oral cavity, facial trichilemmomas, hamartomatous colonic polyps, thyroid neoplasms, breast cancer, and dysplastic gangliocytomas of the cerebellum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-EF48-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239981","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-1C71-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-26","modifiedBy":"ONEDATA","dateModified":"2005-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-EF56-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2974456","version":"1","preferredName":"Cowden Syndrome Diagnostic Criterion Name","preferredDefinition":"A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system._Characteristic or indicative of (e.g., a disease)._That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison._The words or language units by which a thing is known.","longName":"CWD_SYN_DX_CRIT_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"GU tumours (eg, renal cell carcinoma, uterine fibroids) or malformation","valueDescription":"GU tumours (eg, renal cell carcinoma, uterine fibroids) or malformation","ValueMeaning":{"publicId":"2974457","version":"1","preferredName":"GU tumours (eg, renal cell carcinoma, uterine fibroids) or malformation","longName":"2974457","preferredDefinition":"GU tumours (eg, renal cell carcinoma, uterine fibroids) or malformation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-EFF8-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F011-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Fibromas","valueDescription":"Fibroma","ValueMeaning":{"publicId":"2974458","version":"1","preferredName":"Fibroma","longName":"2974458","preferredDefinition":"A benign tumor of fibrous or fully developed connective tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibroma","conceptCode":"C3041","definition":"A non-metastasizing neoplasm arising from the fibrous tissue. It is characterized by the presence of spindle-shaped fibroblasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F01B-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F034-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Lipomas","valueDescription":"Lipoma","ValueMeaning":{"publicId":"2974460","version":"1","preferredName":"Lipoma","longName":"2974460","preferredDefinition":"A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipoma","conceptCode":"C3192","definition":"A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F041-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F059-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Fibrocystic disease of the breast","valueDescription":"Breast Fibrocystic Change","ValueMeaning":{"publicId":"2974462","version":"1","preferredName":"Breast Fibrocystic Change","longName":"2974462","preferredDefinition":"A chronic disorder comprising three variants which range from lesions consisting primarily of an overgrowth of fibrous tissue to those characterized by dominance of the proliferation of the epithelial parenchyma to a form of dysplasia characterized by both stromal and epithelial hyperplasia with the formation of cysts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibrocystic Change","conceptCode":"C3039","definition":"Fibrosis associated with cyst formation in the breast parenchyma.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F067-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F080-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"GI hamartomas","valueDescription":"GI hamartomas","ValueMeaning":{"publicId":"2974463","version":"1","preferredName":"GI hamartomas","longName":"2974463","preferredDefinition":"GI hamartomas","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F08A-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F0A3-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Mental retardation (IQ <= 75)","valueDescription":"Mental retardation (IQ <= 75)","ValueMeaning":{"publicId":"2974464","version":"1","preferredName":"Mental retardation (IQ <= 75)","longName":"2974464","preferredDefinition":"Mental retardation (IQ <= 75)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F0AD-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F0C6-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Other thyroid lesions (eg, adenoma or multinodular goitre)","valueDescription":"Other thyroid lesions (eg, adenoma or multinodular goitre)","ValueMeaning":{"publicId":"2974465","version":"1","preferredName":"Other thyroid lesions (eg, adenoma or multinodular goitre)","longName":"2974465","preferredDefinition":"Other thyroid lesions (eg, adenoma or multinodular goitre)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F0D0-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F0E9-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Endometrial carcinoma","valueDescription":"Endometrial Carcinoma","ValueMeaning":{"publicId":"2974467","version":"1","preferredName":"Endometrial Carcinoma","longName":"2974467","preferredDefinition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Carcinoma","conceptCode":"C7558","definition":"A malignant tumor arising from the epithelium that lines the cavity of the uterine body.  The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases.  Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma.  Uterine bleeding is an initial clinical sign.  The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F0F6-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F10F-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Lhermitte-Duclos disease (LDD)","valueDescription":"Lhermitte-Duclos disease","ValueMeaning":{"publicId":"2578716","version":"1","preferredName":"Lhermitte-Duclos disease","longName":"2578716","preferredDefinition":"Dysplastic Gangliocytoma of the Cerebellum (WHO grade I), also called Lhermitte-Duclos disease, is a benign cerebellar mass, which occurs in young adults and is composed of dysplastic ganglion cells.  It is the major CNS manifestation of Cowden Disease, an autosomal dominant condition that causes a variety of hamartomas and neoplasms.(Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysplastic Cerebellar Gangliocytoma","conceptCode":"C8419","definition":"A benign, WHO grade I cerebellar mass, which occurs in young adults and is composed of dysplastic ganglion cells.  It is the major CNS manifestation of Cowden disease, an autosomal dominant condition that causes a variety of hamartomas and neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0089-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"REEVESD","dateModified":"2009-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F123-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Macrocephaly (megalencephaly) ( >= 95th centile)","valueDescription":"Macrocephaly (megalencephaly) (>= 95th centile)","ValueMeaning":{"publicId":"2974468","version":"1","preferredName":"Macrocephaly (megalencephaly) (>= 95th centile)","longName":"2974468","preferredDefinition":"Macrocephaly (megalencephaly) (>= 95th centile)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F12D-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F146-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Thyroid carcinoma, especially follicular thyroid carcinoma","valueDescription":"Thyroid Gland Carcinoma","ValueMeaning":{"publicId":"2581280","version":"1","preferredName":"Thyroid Gland Carcinoma","longName":"2581280","preferredDefinition":"A carcinoma arising from the thyroid gland.  It is usually an adenocarcinoma and includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic. --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A8D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-18","modifiedBy":"ONEDATA","dateModified":"2006-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F15A-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Breast carcinoma","valueDescription":"Breast Carcinoma","ValueMeaning":{"publicId":"2581276","version":"1","preferredName":"Breast Carcinoma","longName":"2581276","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A89-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-18","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F16E-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Mucocutaneous lesions - Mucosal lesions","valueDescription":"Mucocutaneous lesions - Mucosal lesions","ValueMeaning":{"publicId":"2974469","version":"1","preferredName":"Mucocutaneous lesions - Mucosal lesions","longName":"2974469","preferredDefinition":"Mucocutaneous lesions - Mucosal lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F178-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F191-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Mucocutaneous lesions - Papillomatous lesions","valueDescription":"Mucocutaneous lesions - Papillomatous lesions","ValueMeaning":{"publicId":"2974470","version":"1","preferredName":"Mucocutaneous lesions - Papillomatous lesions","longName":"2974470","preferredDefinition":"Mucocutaneous lesions - Papillomatous lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F19B-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F1B4-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Mucocutaneous lesions - Acral keratoses","valueDescription":"Mucocutaneous lesions - Acral keratoses","ValueMeaning":{"publicId":"2974471","version":"1","preferredName":"Mucocutaneous lesions - Acral keratoses","longName":"2974471","preferredDefinition":"Mucocutaneous lesions - Acral keratoses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F1BE-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F1D7-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"},{"value":"Mucocutaneous lesions -Trichilemmomas, facial","valueDescription":"Mucocutaneous lesions -Trichilemmomas, facial","ValueMeaning":{"publicId":"2974472","version":"1","preferredName":"Mucocutaneous lesions -Trichilemmomas, facial","longName":"2974472","preferredDefinition":"Mucocutaneous lesions -Trichilemmomas, facial","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-F1E1-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BD8A964-F1FA-8A21-E040-BB89AD436C37","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2974455","version":"1","preferredName":"Cowden Syndrome Diagnostic Criterion Name","preferredDefinition":"A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.:Characteristic or indicative of (e.g., a disease).:Criteria; a basis for comparison; a reference point against which other things can be evaluated.:The words or language units by which a thing is known.","longName":"C3076:C25482:C25466:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cowden Syndrome","conceptCode":"C3076","definition":"An autosomal dominant hereditary syndrome characterized by a variety of hamartomas and neoplasms including verrucous skin lesions, fibromas of the oral cavity, facial trichilemmomas, hamartomatous colonic polyps, thyroid neoplasms, breast cancer, and dysplastic gangliocytomas of the cerebellum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Diagnostic","conceptCode":"C25482","definition":"Characteristic or indicative of a condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Criterion","conceptCode":"C25466","definition":"That which constitutes a standard from which a judgment can be established, a reference point against which other things can be evaluated, or a basis for comparison.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-EFD4-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD8A964-EFE5-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"ONEDATA","dateModified":"2009-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"International Cowden Consorti","type":"Preferred Question Text","description":"International Cowden Consortium operational criteria for the diagnosis of Cowden Syndrome, v.2000 \"","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD8A964-F23D-8A21-E040-BB89AD436C37","latestVersionIndicator":"Yes","beginDate":"2009-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-29","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeDescription":"Curated for NCI CCR Protocol in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}